Form 4 for RGEN REPLIGEN CORP

Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0000899243-23-004343 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-02-08	2023-02-06	RGEN	Madaus Martin D	Dir	A - Grant	$0.00	+111	111	New	$0
DM	2023-02-08	2023-02-06	RGEN	Madaus Martin D	Dir	A - Grant	$0.00	+2,058	1,819	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-06	A	A	111	$0.00	111	D	—	—	(F1) Mr. Madaus was awarded 111 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 18, 2023, the date of the annual meeting of the Company's shareholders. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
2	Derivative	Stock Option (Right to Buy)	2023-02-06	A	A	239	$0.00	239	D	$192.02 · 2023-05-18 to 2033-02-06	239 Common Stock	(F2) Award vests in full on May 18, 2023, the date of the annual meeting of the Company's shareholders.
3	Derivative	Stock Option (Right to Buy)	2023-02-06	A	A	1,819	$0.00	1,819	D	$192.02 · 2024-02-06 to 2033-02-06	1,819 Common Stock	(F3) The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period.